TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  News From NINDS  »  News Articles  » 

Skip secondary menu

NINDS News Articles


   


 

NIH-NINDS logo

NIH-supported NeuroBioBank joins Autism BrainNet in brain donation initiative
Tuesday, Nov 17 2015
The National Institute of Mental Health (NIMH) has signed an agreement to establish a collaborative, nationwide effort for the collection, storage, and distribution of postmortem human brain tissue for the benefit of autism research. The agreement with Foundation Associates LLC will coordinate the efforts of two independent networks of human brain tissue repositories, the National Institutes of Health NeuroBioBank (NBB) and the Autism BrainNet (ABN).

GluCEST MRI

New brain imaging technique identifies previously undetected epileptic seizure sites
Thursday, Nov 12 2015
People with epilepsy experience uncontrolled seizures that can impair quality of life and cause stigma that leads to social isolation. The neurological condition can limit some activities most people take for granted, such as sustaining work or operating a vehicle. Researchers at the University of Pennsylvania and funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed a non-invasive brain imaging technique for a class of patients whose epilepsy symptoms do not respond to drug treatment and who would otherwise be poor candidates for seizure-relieving surgeries.

NINDS congratulates Beth Stevens, winner of a 2015 MacArthur Foundation Fellowship

NINDS congratulates Beth Stevens, winner of a 2015 MacArthur Foundation Fellowship
Monday, Sep 28, 2015
On September 28, 2015, Dr. Stevens was awarded a 2015 MacArthur Foundation Fellowship for her work on microglia and brain development. NINDS congratulates Dr. Stevens.

Landmark NIH study shows intensive blood pressure management may save lives

Landmark NIH study shows intensive blood pressure management may save lives
Friday, Sep 11, 2015
More intensive management of high blood pressure, below a commonly recommended blood pressure target, significantly reduces rates of cardiovascular disease, and lowers risk of death in a group of adults 50 years and older with high blood pressure. This is according to the initial results of a landmark clinical trial sponsored by the National Institutes of Health called the Systolic Blood Pressure Intervention Trial (SPRINT) (NIH).

NIH-NINDS logo

NIH and CDC Announce Grantees for the Sudden Death in the Young Registry
Wednesday, Oct 15, 2014
The NIH and CDC announce awards to ten grantees for the Sudden Death in the Young Registry. Six are current or former grantees from the Sudden Unexpected Infant Death (SUID) Registry: Georgia, Michigan, Minnesota, New Hampshire, New Jersey, and Wisconsin. Four are new grantees: Delaware, Tennessee, the city of San Francisco and the Tidewater region of Virginia. Grants were awarded on September 30, 2014. After a period of training and preparation, the grantees will begin reviewing cases in January 2015.

New NIH logo

New members selected for National Advisory Neurological Disorders and Stroke Council
Thursday, Feb 4, 2016
Six esteemed individuals have been selected to serve on the National Advisory Neurological Disorders and Stroke Council, the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.

Mind Your Risks Campaign Poster

NIH Launches New Public Health Campaign
Tuesday, Feb 2, 2016
A growing body of scientific evidence indicates that uncontrolled high blood pressure is not only the leading cause of stroke but may also be linked to cognitive decline and dementia. Today, the National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke (NINDS) is launching a public health education campaign called Mind Your Risks.

Blueprint Neurotherapeutics logo

New NIH-funded memory drug moves into Phase 1 clinical study
Thursday, Dec 31, 2015
An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, a program designed to facilitate the discovery and development of novel neurological treatments. It is the first compound funded by the program to reach a Phase 1 clinical trial.

Proteasomes and Brain Cell Death

Speeding up brain’s waste disposal may slow down neurodegenerative diseases
Monday, Dec 21, 2015
A study of mice shows how proteasomes, a cell’s waste disposal system, may break down during Alzheimer’s disease (AD), creating a cycle in which increased levels of damaged proteins become toxic, clog proteasomes, and kill neurons. The study, published in Nature Medicine and supported by the National Institutes of Health, suggests that enhancing proteasome activity with drugs during the early stages of AD may prevent dementia and reduce damage to the brain.

Thalamus tunes the brain activity

Scientists manipulate consciousness in rats
Friday, Dec 18, 2015
Scientists showed that they could alter brain activity of rats and either wake them up or put them in an unconscious state by changing the firing rates of neurons in the central thalamus, a region known to regulate arousal. The study, published in eLIFE, was partially funded by the National Institutes of Health.


New NIH logo

Researchers find essential brain circuit in visual development
Monday Aug 26, 2013
A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain. The research, funded by the National Institutes of Health, has implications for treating amblyopia, a vision disorder that occurs when the brain ignores one eye in favor of the other.

More News Articles

Qualified media representatives can arrange interviews and photos with NINDS researchers and administrators. E-Mail or call (301) 496-5751.
Office of Communications And Public Liaison
Building 31, Room 8A-16
31 Center Drive MSC 2540
P.O. Box 5801
Bethesda, MD 20824